Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Progressive supranuclear palsy revisited

I Litvan1

  • 1Defense & Veteran Head Injury Program, Henry M. Jackson Foundation, Medical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892-9130, USA.

Acta Neurologica Scandinavica
|January 6, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of sporadic and familial behavioral variant frontotemporal dementia (FTD) in a North American cohort.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2020
Same author

Active lifestyles moderate clinical outcomes in autosomal dominant frontotemporal degeneration.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2020
Same author

Swallowing disturbances in the corticobasal syndrome.

Parkinsonism & related disorders·2015
Same author

Roles of Education and IQ in Cognitive Reserve in Parkinson's Disease-Mild Cognitive Impairment.

Dementia and geriatric cognitive disorders extra·2012
Same author

Mild cognitive impairment in Parkinson's disease.

Minerva medica·2011
Same author

Incidence of and risk factors for cognitive impairment in an early Parkinson disease clinical trial cohort.

Neurology·2009
Same journal

Editorial.

Acta neurologica Scandinavica·2022
Same journal

Advances in sudden unexpected death in epilepsy.

Acta neurologica Scandinavica·2022
Same journal

Non-convulsive seizures and non-convulsive status epilepticus in neuro-intensive care unit.

Acta neurologica Scandinavica·2022
Same journal

Positron emission tomography in autoimmune encephalitis: Clinical implications and future directions.

Acta neurologica Scandinavica·2022
Same journal

Seizure detection based on wearable devices: A review of device, mechanism, and algorithm.

Acta neurologica Scandinavica·2022
Same journal

Walking confidence and perceived locomotion ability explain participation after stroke: A cross-sectional experimental study.

Acta neurologica Scandinavica·2022
See all related articles

This review revisits progressive supranuclear palsy (PSP) aspects, including history, genetics, and treatments. It also highlights emerging research avenues for this rare neurological disorder.

Area of Science:

  • Neurology
  • Neuroscience

Context:

  • Progressive supranuclear palsy (PSP) is a rare, fatal neurodegenerative disease.
  • Understanding its multifaceted aspects is crucial for advancing patient care.

Purpose:

  • To provide a comprehensive overview of current knowledge on progressive supranuclear palsy (PSP).
  • To identify and discuss novel research directions in PSP.

Summary:

  • This review consolidates information on the historical, epidemiological, genetic, clinical, neuropathological, neurochemical, diagnostic, and therapeutic facets of PSP.
  • It examines the latest findings and outlines future research priorities.

Impact:

  • Enhances understanding of progressive supranuclear palsy (PSP) for researchers and clinicians.

Related Experiment Videos

  • Guides future research efforts to improve diagnosis and treatment of PSP.